Pelthos Therapeutics to report Q1 2026 financial results on May 14 with a conference call.

Pelthos Therapeutics, a biopharmaceutical company specializing in treatments for cutaneous infectious diseases, will announce its first quarter 2026 financial results on May 14, 2026. The company will hold a conference call at 8:30 a.m. Eastern Time to discuss the results and answer questions. Pelthos is known for products like ZELSUVMI™ gel for Molluscum contagiosum, Xepi® cream for impetigo, and Xeglyze® for head lice. Investors and interested parties can join the webcast or call using provided details.